Neisseria Meningitidis Serogroup C Tetanus Toxoid Conjugate Vaccine
This vaccine protects against Neisseria meningitidis serogroup C, a bacteria that causes serious infections like meningitis and bloodstream infections. It works by stimulating the immune system to produce antibodies against the bacterial capsule, and is routinely given to infants, children, and adolescents as part of many national immunization programs.
A conjugate vaccine that prevents meningococcal C disease by training the immune system to recognize and fight Neisseria meningitidis serogroup C bacteria.
Key facts at a glance
- RxNorm
- 2360572
- Generic
- Neisseria Meningitidis Serogroup C Capsular Polysaccharide Tetanus Toxoid Protein Conjugate Vaccine
- Class
- unclassified
- Brands
- Menquadfi, Penbraya
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- injection
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup C, including meningitis, meningococcemia, and septicemia. It is part of routine childhood and adolescent immunization schedules in many countries.
The vaccine contains capsular polysaccharide from serogroup C bacteria conjugated to tetanus toxoid protein. This conjugation converts a T-cell independent antigen into a T-cell dependent antigen, enhancing immune response and generating durable protective antibodies, particularly effective in young children.
Administered via intramuscular injection. Common side effects include injection site reactions, mild fever, and irritability. Contraindicated in individuals with severe allergic reactions to any vaccine component. Not a treatment for active infection. Vaccination does not protect against other meningococcal serogroups.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 29, 2026. · Read our editorial policy